SCHEMBL14499481

SCHEMBL14499481

O=C(O)c1ccc(-c2nnc(CCCCCCCc3ccccc3)o2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
CES1 P23141 3/20 0.57
HDAC6 Q9UBN7 2/20 0.54
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
FAAH O00519 3/20 0.53
RARB P10826 4/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14499473 1.00 NPC1 (0.60) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL14499477 1.00 NPC1 (0.60) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL14499470 0.99 NPC1 (0.61) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL5640767 0.96 RAB9A (0.61) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL5637997 0.91 NPC1 (0.65) NPC1RAB9ACES1HDAC6CA1
SCHEMBL14499476 0.87 FAAH (0.57) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL14499480 0.87 FAAH (0.57) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL14499472 0.87 FAAH (0.57) NPC1RAB9ACES1HDAC6HDAC3
SCHEMBL7333177 0.85 RARB (0.57) NPC1RAB9AHDAC6HDAC3HDAC4
SCHEMBL14499469 0.85 FAAH (0.55) NPC1RAB9ACES1HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed